[1]
Dr.Padmaja Shetty K et al. 2024. A REAL WORLD SAFETY STUDY ON DAPAGLIFOZIN, A PRELIMINARY ACTIVE SURVEILLANCE IN A TERTIARY CARE SETTING. Journal of Population Therapeutics and Clinical Pharmacology. 31, 4 (Apr. 2024), 576–584. DOI:https://doi.org/10.53555/jptcp.v31i4.5371.